Your browser doesn't support javascript.
loading
Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells.
Abdin, Shifaa M; Tolba, Mai F; Zaher, Dana M; Omar, Hany A.
Afiliação
  • Abdin SM; Sharjah Institute for Medical Research, University of Sharjah, United Arab Emirates; College of Medicine, University of Sharjah, Sharjah, 27272, United Arab Emirates.
  • Tolba MF; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt; School of Life and Medical Sciences, University of Hertfordshire hosted by Global Academic Foundation, New Capital City, Egypt. Electronic address: tolba.mf@pharma.asu.edu.eg.
  • Zaher DM; Sharjah Institute for Medical Research, University of Sharjah, United Arab Emirates; College of Medicine, University of Sharjah, Sharjah, 27272, United Arab Emirates.
  • Omar HA; Sharjah Institute for Medical Research, University of Sharjah, United Arab Emirates; College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62511, Egypt. Electronic address: ha
Chem Biol Interact ; 340: 109450, 2021 May 01.
Article em En | MEDLINE | ID: mdl-33775688
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Transdução de Sinais / NF-kappa B / Resistência a Múltiplos Medicamentos / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Tipo de estudo: Guideline Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Transdução de Sinais / NF-kappa B / Resistência a Múltiplos Medicamentos / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Tipo de estudo: Guideline Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article